The influence of statin withdrawal and adherence on stroke outcomes

Bruno Kusznir Vitturi1, Rubens José Gagliardi2

  • 1Department of Neurology, Santa Casa de São Paulo School of Medical Sciences, Dr. Cesário Motta Júnior Street 112, São Paulo, 01221-020, Brazil. z_azul@hotmail.com.

Insights

Suboptimal statin use in ischemic stroke patients is linked to worse outcomes. Good adherence to statin therapy is crucial for better functional recovery and reduced stroke recurrence.

Area of Science:

  • Cardiovascular Research
  • Neurology
  • Pharmacology

Background:

  • Statin therapy is a cornerstone in preventing strokes due to its proven benefits.
  • Understanding factors influencing statin adherence is vital for optimizing patient outcomes.

Purpose of the Study:

  • To investigate risk factors associated with poor statin adherence or interruption in ischemic stroke patients.
  • To evaluate the impact of suboptimal statin use on clinical outcomes, including stroke recurrence and functional recovery.

Main Methods:

  • A prospective cohort study of 479 acute ischemic stroke patients (2014-2018) was conducted.
  • Patients were categorized based on statin adherence and withdrawal, with follow-up for 24 months.
  • Outcomes assessed included stroke recurrence, major cardiovascular events, mortality, and functional performance using the modified Rankin Scale.

Main Results:

  • Poor statin adherence was associated with hypertension, prior stroke, and large-artery atherosclerosis.
  • Patients with poor adherence or statin withdrawal experienced worse functional outcomes and increased stroke recurrence.
  • Satisfactory statin adherence was linked to significant functional recovery.

Conclusions:

  • Suboptimal statin use, including poor adherence and withdrawal, significantly worsens clinical outcomes in ischemic stroke patients.
  • Maintaining good statin adherence is critical for improving functional recovery and reducing secondary stroke events.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
221
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
214
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
105
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
103
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
4.5K